Could supervised exercise be safe for High-Risk heart patients?
NCT ID NCT07708311
First seen Jul 16, 2026 · Last updated Jul 21, 2026 · Updated 3 times
Summary
This trial investigates whether a structured, moderate-intensity cardiac rehabilitation program is safe for people with arrhythmogenic cardiomyopathy who carry high-risk genetic mutations. Participants will be randomly assigned to either the exercise program or standard physical restriction. The study aims to see if supervised exercise can improve fitness and quality of life without increasing dangerous heart rhythms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a supervised, moderate-intensity cardiac rehabilitation program
- What this could lead to
- If successful, this could provide a safe way for high-risk patients to exercise, improving their physical fitness and quality of life without triggering dangerous heart rhythms.
- What could go wrong
- This is an early exploratory trial with only 70 participants, so results may not apply to all patients. The exercise program could still increase arrhythmia risk in some individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC CARDIOMYOPATHY (AC, ARVD/C) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.